| Recent
Patents on Drug Delivery & Formulation
ISSN: 1872-2113 - Volume 2, 3 Issues, 2008

Editor:
Khurshid Zaman
Bentham Science Publishers Ltd.
Editorial Advisory Board:
A. Agrawal (Dyodelta Biosciences
Ltd, Cambridgeshire, UK)
C. Allen (University of Toronto, Toronto, Canada)
A.I. Alvarez (University of Leon Campus Vegazana,
Leon, Spain)
M. Amiji (Northeastern University, Boston,
MA, USA)
B.G. Amsden (Queen's Univ., Kingston, ON,
Canada)
A.G. Asuero (The University of Seville, Seville,
Spain)
M.B. Bally (British Columbia Cancer Agency,
Vancouver, Canada)
E.H. Barash (Chief Patent Counsel, West
Lafayette, IN, USA)
A.W. Basit (University of London, London,
UK)
S. Benita (Hebrew University of Jerusalem,
Jerusalem, Israel)
E. Bilensoy (Hacettepe University, Ankara,
Turkey)
G. Bonora (Università di Trieste,Trieste,
Italy)
S. Brocchini (University of London, London,
UK)
M. Brunner (Medical Univ. of Vienna, Vienna,
Austria)
G. Buckton (University of London, London,
UK)
F.J. Burczynski (University of Manitoba,
Manitoba, Canada)
M. Bourin (Universite de Nantes, Cedex, France)
N. Çelebi (Gazi University, Ankara,
Turkey)
M. Cemazar (Institute of Oncology, Ljubljana,
Solvenia)
H.K. Chan (University of Sydney, Sydney,
Australia)
P. Colombo (Parco Area delle Scienze, Parma,
Italy)
P.P. Constantinides (Biopharmaceutical &
Drug Delivery Consulting, LLC, IL, USA)
R. Conti (Univ.of Pavia, Pavia, Italy)
T. Coviello (Universita La Sapienza, Rome,
Italy)
C. Davidson (Davidson, Davidson & Kappel,
LLC, New York, NY, USA)
R.F. Donnelly (Queens Univ. Belfast, Belfast,
UK)
A.O.S. El-Kadi (Univ.of Alberta, Alberta,
Canada)
J.-Y. Fang (Chang Gung Univ., Taoyuan, Taiwan)
S.-S. Feng (National University of Singapore,
Singapore)
B. Finnin (Monash University, Parkville,
Australia)
R. Gessner (Virchow Hospital, Berlin, Germany)
M.C. Gohel (L.M.College of Pharmacy, Gujarat,
India)
G. Golomb (The Hebrew Univ.of Jerusalem,
Jerusalem, Israel)
L. González-Mariscal (Center for Res.
and Adv. Studies, México, Mexico)
H. Harashima (Hokkaido University, Hokkaido,
Japan)
K.R. Jadhav (Bharati Vidyapeeths Coll.of
Pharmacy, Mumbai, India)
Y. Kost (Ben Gurion University of the Negev,
Beer Sheva, Israel)
G.S. Kwon (University of Wisconsin, Madison,
WI, USA)
A.G. Lacko (University of North Texas Health
Science Center,Texas, TX, USA)
A. Lamprecht (Univ.of Franche-Comté,
France)
B.-J. Lee (Kangwon National University, Chuncheon,
Korea)
B. Lebleu (CNRS, Paris, France)
H. Lennernas (Uppsala Univ., Uppsala, Sweden)
J. Lisziewicz (The Therapeutic Vaccine Company,
Washington, WA, USA)
Y. Maitani (Hoshi University, Tokyo, Japan)
T. Minko (The State University of New Jersey,
Piscataway, NJ, USA)
A. Misra (The Maharaja Sayajirao Univ. of
Baroda, Vadodara, India)
A.K. Mitra (Univ.of Missouri-Kansas City,
Kansas City, MO, USA)
S.M. Moghimi (University of Brighton, Brighton,
UK)
M. Morishita (Hoshi Univ., Tokyo, Japan)
L. Mu (Rexahn Pharmaceuticals, Inc., Rockville,
MD, USA)
S.N. Murthy (The Univ. of Mississippi, Oxford,
MS, USA)
Y. Obata (Hoshi University, Tokyo, Japan)
M. Ogris (Ludwig-Maximilians-Universitat,
Munich, Germany)
A. Omri (Laurentian University,Ontario, ON,
Canada)
Y. Perrie (Aston University, Birmingham,
UK)
V. Pillay (University of the Witwatersrand,
Johannesburg, South Africa)
R.L. Remmele (Amgen Inc., CA, USA)
D.K. Sarker (The University of Brighton,
Brighton, UK)
A.G. Schatzlein (Univ. of Glasgow, Glasgow,
UK)
R.M. Schiffelers (Utrecht Inst. for Pharmaceut.
Sciences, Utrecht, Netherlands)
B.N. Singh (Forest Laboratories, Inc., Commack,
NY, USA)
M. Singh (Chiron Corporation, Emeryville,
CA, USA)
J. Singh (North Dakota State Univ., Fargo,
ND, USA)
P.J. Sinko (The State Univ. of New Jersey,
New Jersey, NJ, USA)
A. Sintov (Ben-Gurion University of the Negev
, Beer-Sheva, Israel)
J. Smart (University of Brighton, Brighton,
UK)
G. Smaldone (State Univ. of New York at Stony
Brook, New York, NY, USA)
S. Srcic (Univ.of Ljubljana, Ljubljana, Slovenia)
S. Svenson (Dendritic NanoTechnologies Inc.,
Mount Pleasant, MI , USA)
A.G. Thombre (Pfizer Inc.,Groton, CT, USA)
I. Toth (University of Queensland, Brisbane,
Australia)
V.P. Torchilin (Northeastern Univ., Boston,
MA, USA)
M.L. Torre (Univ. of Pavia, Pavia, Italy)
E. Touitou (The Hebrew University of Jerusalem,
Jerusalem, Israel)
I.F. Uchegbu (Univ.of Strathclyde, Strathclyde,
Glasgow, UK)
G. van den Mooter (Katholieke Univ. Leuven,
Leuven, Belgium)
S. Venkatraman (School of Materials Sci.
& Eng., Singapore)
H. Viernstein (University of Vienna, Vienna,
Austria)
G.A. Voyiatzis (Inst. of Chemical Engineering,
Patras, Greece)
S.P. Vyas (Dr. Harisingh Gour Univ., Sagar,
India)
M. Webb (British Columbia Cancer Research
Centre, Vancouver, Canada)
T. Yasukawa (Nagoya City University, Nagoya,
Japan) |